Results 131 to 140 of about 14,877 (300)
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.
British Journal of Clinical Pharmacology, 2016 J. Siller-Matula +8 more
semanticscholar +1 more source
The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions
, 1999 Verghese Mathew +6 more
openalex +1 more source
Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis [PDF]
, 2001 J.P. Collet +6 more
openalex +1 more source
Vitae, 2009 Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G +4 more
doaj
Drug-Eluting Stents in Primary Angioplasty Long-Term Clinical Outcomes [PDF]
, 2007 INTRODUCTION: The use of drug-eluting stents in the context of mechanical reperfusion following ST-segment elevation myocardial infarction (MI) was initially viewed with concern. The main fear was that the drugs' action in unstable lesions could increase
Bernardes, L +8 more
core
Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention
BMJ Case Reports, 2017 Todd Golden +3 more
semanticscholar +1 more source
Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab [PDF]
, 2001 Jay D. Schlaifer +2 more
openalex +1 more source
Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]
Cureus, 2023 Hasan N +9 more
europepmc +1 more source